Loading...
Predictive indicators of successful tyrosine kinase inhibitor discontinuation in patients with chronic myeloid leukemia
Clinical trials have demonstrated that some patients with chronic myeloid leukemia (CML) treated for several years with tyrosine kinase inhibitors (TKIs) who have maintained a molecular response can successfully discontinue treatment without relapsing. Treatment free remission (TFR) can be reached b...
Na minha lista:
| Udgivet i: | World J Clin Oncol |
|---|---|
| Main Authors: | , , , , , , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
Baishideng Publishing Group Inc
2020
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7769711/ https://ncbi.nlm.nih.gov/pubmed/33437662 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.5306/wjco.v11.i12.996 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|